Heme Queen's Avatar

Heme Queen

@heme-queen.bsky.social

Mother Runner Coffee-lover Hematology fellow #HemeSky #MedSky

137 Followers  |  72 Following  |  12 Posts  |  Joined: 16.11.2024  |  1.8324

Latest posts by heme-queen.bsky.social on Bluesky

Post image

One week left to apply for the HTRS Trainee Workshop Spring 2026!

Apply by Dec 15, 2025: www.htrs.org/continuing-p...

08.12.2025 18:04 β€” πŸ‘ 0    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image

We are excited to welcome thirty medical trainees to Orlando, Florida, for the HTRS Trainee Workshop: Winter 2025. This year’s cohort will have the opportunity to learn from our distinguished faculty through an engaging and immersive program.

03.12.2025 20:42 β€” πŸ‘ 0    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image

🌍 Reminder: ASH International Outreach Initiative Applications Now Open!

The ASH IOI aims to bridge the gap in #hematology education by offering free educational resources to institutions in low- and middle-income countries.

πŸ”— https://bit.ly/4liN3yc

#HemeSky #MedSky

22.10.2025 11:05 β€” πŸ‘ 5    πŸ” 4    πŸ’¬ 0    πŸ“Œ 0

PCP has pt on 4 agents for sleep/RLS…has never checked iron…ferritin of 6…what are we doing chat

23.10.2025 00:07 β€” πŸ‘ 20    πŸ” 2    πŸ’¬ 4    πŸ“Œ 1
Post image

🚨Abstract submissions for EAHAD 2026 are now open! Share your research with leading experts in haemophilia and bleeding disorders before 27 October ➑️

02.09.2025 06:01 β€” πŸ‘ 0    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image

Pass the hematology boards with flying colors! πŸ’«

Join the ASH Hematology Review Series for expert lectures and live sessions until October 6. Enroll today: https://bit.ly/3RR5bCN

#ABIM #HemeSky #MedSky #BoardExamsPrep

22.08.2025 13:00 β€” πŸ‘ 0    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0

Heme fellows apply! Networking and career mentorship !

#hemesky #meded

01.08.2025 21:59 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

Good news! The Senate’s leadership is proposing a $400M NIH funding increase for FY26. Now ASH urges the House to support the Senate numbers. ASH can’t do it aloneβ€”join the #Fight4Hematology: call, email, or meet with your Rep today. πŸ”— https://bit.ly/3YeapvY

01.08.2025 18:02 β€” πŸ‘ 6    πŸ” 3    πŸ’¬ 0    πŸ“Œ 2

It looks like there is an error- the answer should be D :)

01.08.2025 00:14 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

Interested in a mentor to guide your career in malignant hematology? Apply for the ASH’s new Mentorship Program, and grow your network! Deadline: Sept 26. Apply today! πŸ”— https://bit.ly/3IPWjMA

Interested in becoming a mentor? Sign up today: https://bit.ly/3U5tm1t

#HemeSky

31.07.2025 18:30 β€” πŸ‘ 4    πŸ” 2    πŸ’¬ 0    πŸ“Œ 1
ASH Foundation The ASH Foundation is dedicated to moving hematology forward through charitable support for ASH programs Γ’β‚¬β€œ helping hematologists conquer blood diseases worldwide.

So impressed at the increased support the American Society of Hematology is planning for trainees and early-career investigators!! At some point, someone invested in us. Now it’s our turn. #Fight4Hematology and secure the future of hematology research. Donate! #hemesky www.hematology.org/foundation

31.07.2025 14:35 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Preview
Gene-based therapies for hemophilia Gene therapy is a transformative approach to treating genetic disorders in order to improve disease outcomes for patients. Hemophilia A and B are inherited genetic disorders caused by mutations in the...

πŸ’‘An exciting illustrated review of "Gene-based therapies for hemophilia," by Wolfgang Miesbach et al is now available as full-OA article in @isth.org @rpth.bsky.social!
It provides a compreh. overview of #genetherapy for #hemophilia A & B, highlighting recent advances in patient care.
bit.ly/40RHmQ8

17.07.2025 16:02 β€” πŸ‘ 4    πŸ” 3    πŸ’¬ 0    πŸ“Œ 0
Figure 1.  Pathophysiology of Immune Thrombotic Thrombocytopenic Purpura

Figure 1. Pathophysiology of Immune Thrombotic Thrombocytopenic Purpura

Immune thrombotic thrombocytopenic purpura (iTTP) is a rare immune-mediated disorder characterized by thrombocytopenia and microangiopathic hemolytic anemia, potentially causing life-threatening thrombosis.

Learn more in this Review.

https://ja.ma/4krNDZU

05.07.2025 14:00 β€” πŸ‘ 9    πŸ” 3    πŸ’¬ 0    πŸ“Œ 0
Post image Post image

Meta-analysis on GLP-1RA (vs. placebo) and VTE:
πŸ”Ή PE rates significantly lower πŸ“‰
πŸ”Ή VTE rates lower but not statistically significant
πŸ”Ή No difference in DVT
πŸ”Ή Study design matters: RCTs vs. observational data
Accepted for publication in JTH!
#ISTH2025 #VTE #GLP1RA #Thrombosis
@jthjournal.bsky.social

23.06.2025 19:42 β€” πŸ‘ 16    πŸ” 7    πŸ’¬ 0    πŸ“Œ 2
Post image Post image Post image Post image

This is what we were waiting for. A direct comparison between apixaban and rivaroxaban for the treatment of acute VTE. Apixaban reduces bleeding risk in the first 3 months by >50%!

Practice changing investigator-initiated RCT.

#ISTH2025

22.06.2025 13:49 β€” πŸ‘ 72    πŸ” 37    πŸ’¬ 4    πŸ“Œ 7
Post image

Day 3 of #ISTH2025 with the Hopkins Complement Crew #hemesky

23.06.2025 15:15 β€” πŸ‘ 3    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0
Post image Post image Post image Post image

Why is managing hypertensive disorders during pregnancy challenging? Tune in with Drs. Richard Burwick and Shruti Chaturvedi for a new HemeTalks episode for insights on pre-eclampsia, diagnostic tests, and management strategies! 🎧 https://bit.ly/3XwnXCD

#HemeSky @ash.edu.hematology.org‬

19.06.2025 19:00 β€” πŸ‘ 3    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Preview
2025 focused update of the 2020 ISTH guidelines for management of thrombotic thrombocytopenic purpura - PubMed For patients with iTTP, no change to 2020's recommendations. For patients with cTTP, the panel supports ADAMTS-13 replacement. Where accessible, recombinant ADAMTS-13 provides the most favorable balan...

Updated Guidelines in TTP treatment just dropped at #ISTH2025

pubmed.ncbi.nlm.nih.gov/40533296/

19.06.2025 23:15 β€” πŸ‘ 2    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0
Post image Post image Post image Post image

Why do some people with the Duffy null phenotype have an ANC below most institutional reference ranges? Explore the mechanism behind this phenomenon πŸ‘‡

Learn more: www.hematology.org/e...

#DuffyNull #HemeSky #MedSky #DANC #ASHEducation @ash.edu.hematology.org

20.05.2025 16:52 β€” πŸ‘ 9    πŸ” 4    πŸ’¬ 0    πŸ“Œ 0
Post image

Platelet refractoriness describes a poor response to platelet transfusion, and conventional thinking has divided etiologies into 2 broad categories: immune and nonimmune. buff.ly/JEfMzzB #hemesky #transfusionmedicine #HowITreat

21.05.2025 13:03 β€” πŸ‘ 3    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0
Post image

#ASHSlideSaturday 🩸: Examine the slide from the #ASHImageBank. Identify the cells and where you may see them.

Tune in tomorrow for the answer!

#ASHEducation #Microlearning #MedEd #Hemesky #Hematology #Hematologist #MedicalEducation #TIL

10.05.2025 12:01 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image

Super amazing opportunity for students and trainees interested in hematology! #MedSky

11.04.2025 19:48 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0

The entire CDC lead program has been eliminated.

Lead exposure can lead to many issues including anemia & irreversible brain damage in young children.

It was <10 years ago we learned that 99,000 people in Flint Michigan had been exposed.

If only eliminating programs eliminated the risk.

11.04.2025 20:31 β€” πŸ‘ 964    πŸ” 381    πŸ’¬ 33    πŸ“Œ 38

Mild neutropenia may not need a bone marrow biopsy….

DANC can be diagnosed with just a quick easy blood test!

11.04.2025 19:01 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Groups Demand RFK Jr. 'Immediately' Restore CDC's Axed Blood Division ASH, others warn of preventable hospitalizations and deaths for Americans with blood disorders

Now the D-team has chainsawed the CDC Division of Blood Diseases...
Thanks @ash.hematology.org 90+ other organizations for speaking up!
This action has immediate harms to the health of Americans.
www.medpagetoday.com/hematologyon...

09.04.2025 20:21 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Preview
Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism | NEJM In patients with active cancer and venous thromboembolism, whether extended treatment with a reduced dose of an oral anticoagulant is effective in preventing recurrent thromboembolic events and dec...

Super exciting results regarding extended dose reduction of Apixaban in cancer- associated VTE #hemesky

www.nejm.org/doi/full/10....

09.04.2025 22:59 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

If you are a healthcare provider and EVER draw labs to evaluate for iron deficiency you should know

-ferritin is best unless ongoing inflammation
-serum iron is USELESS
-a single digit ferritin result is NEVER NORMAL even if your lab says it is

#MedSky

09.04.2025 22:30 β€” πŸ‘ 185    πŸ” 30    πŸ’¬ 9    πŸ“Œ 2
ASH Trainee Council - Hematology.org ASH Trainee Council

Have you put in your application for the ASH Trainee Council? Open for just 6 more days! Med students, international trainees, PhD students and post docs, residents, fellows - you are eligible!

www.hematology.org/education/tr...

24.03.2025 15:00 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

❓Are you ready for #Hemophilia rebalancing therapies?
πŸ’‘Join the @isth.org webinar on how to assess emerging rebalancing therapies & prepare treatment teams for their use
πŸŽ™οΈSpeakers: Speaker(s): Amy Shapiro, Stacy Croteau
πŸ—“οΈFeb. 26, 2025 15:00 PM UTC
πŸ‘‰https://buff.ly/3E77Apo

05.02.2025 15:30 β€” πŸ‘ 5    πŸ” 3    πŸ’¬ 0    πŸ“Œ 0

@heme-queen is following 20 prominent accounts